Walvax Biotechnology Co., Ltd. (SHE:300142)
11.45
+0.22 (1.96%)
Jun 9, 2026, 3:10 PM CST
10.41% (1Y)
| Market Cap | 18.31B +10.7% |
| Revenue (ttm) | 2.40B -10.6% |
| Net Income | 285.77M +118.7% |
| EPS | 0.18 +115.5% |
| Shares Out | 1.60B |
| PE Ratio | 64.53 |
| Forward PE | 61.07 |
| Dividend | 0.16 (1.38%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 46,033,127 |
| Open | 11.99 |
| Previous Close | 11.23 |
| Day's Range | 10.98 - 11.99 |
| 52-Week Range | 10.05 - 16.23 |
| Beta | 0.39 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 24, 2026 |